Clinical trial
Beryllium Infliximab Study: Clinical Interventional Trial
NCT00111917 · Maier, Lisa, M.D., Other · Terminated
Key facts
| NCT number | NCT00111917 |
|---|---|
| Title | Beryllium Infliximab Study: Clinical Interventional Trial |
| Official title | Clinical Efficacy of Remicade in Chronic Beryllium Disease: A Randomized, Double-Blind, Placebo-Controlled, Investigator Initiated Trial |
| Acronym | BISCIT |
| Lead sponsor | Maier, Lisa, M.D., Other |
| Collaborators | Centocor, Inc. Industry National Center for Research Resources (NCRR) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Berylliosis, Beryllium Disease |
| Intervention type | Drug, Other |
| Interventions | Infliximab, Placebo |
| Enrollment | 13 |
| Start date | Feb 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | May 27, 2005 |
| Last update posted | Jun 2, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: